MOONLIGHT THERAPEUTICS, INC.

Marietta, GA · Medtech · Private

Microneedle patch for targeted allergen immunotherapy to treat peanut allergy

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · moonlighttx.com

Sector: Medtech
Headquarters: Marietta, GA
Latest Form D: $2.4M, Aug 2024
Total capital: $6.1M

Federal grants: $3.7M; 6 awards · 2019–2023; Rank in peer group#251 of 538
Private capital raised: $2.4M; 1 Form D · last Aug 2024; 26 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Aug 2024Private capital raisedForm D · SEC · 1st filing$2.4M
Apr 2023Federal grantHealth and Human S · Phase I · Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy$300K
Apr 2022Federal grantHealth and Human S · Phase II · Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies$919K
May 2021Federal grantHealth and Human S · Phase II · Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies$1.9M
Jun 2020Federal grantHealth and Human S · Phase II · Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies$55K
Feb 2020Federal grantHealth and Human S · Phase II · Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies$298K
Mar 2019Federal grantHealth and Human S · Phase II · Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies$298K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

65months

from MOONLIGHT THERAPEUTICS, INC.’s first federal award to its first private round.

First federal award · Mar 2019: Health and Human S · $298K
First Form D · Aug 2024: $2.4M · 1st Form D
Awards before first raise: 6 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#251 · top 47%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Samirkumar PatelResearcherExecutive Officer, DirectorLinked by $3.7M in grants as PI
Harold ShlevinDirectorNamed in SEC Form D filings
Ritu ShahDirectorNamed in SEC Form D filings
Vladimir ZarnitsynExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

NANOCYTOMICS LLCSimilar federal contract value in Medtech · null in contracts
NEUROGAMI MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
VESTECK, INCSimilar federal contract value in Medtech · null in contracts
ARADIGM CORPORATIONSimilar federal contract value in Medtech · null in contracts
GLOBAL TACTILE, LLCSimilar federal contract value in Medtech · null in contracts
Plasmacord, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.